Vector Labs decouples from Maravai, popping up shop with private capital, new CEO on board
Vector Laboratories has been in business since the 1970s, developing and manufacturing protein detection to help study tissues and cells. After Tuesday, the team will do so as a stand-alone company flush with private capital and headed by a new CEO.
Vector announced a $124 million cash buyout backed by private equity firm Thompson Street Capital Partners on Tuesday to fund its expansion in protein detection. The money will help Vector with future mergers and acquisitions, and help commercialize its labeling and detection technology in its pipeline.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.